Effectiveness of dietary interventions on cardio-metabolic risk factors in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials

被引:1
|
作者
Ghadimi, Maryam [1 ,2 ]
Mohammadi, Reihaneh [2 ]
Daneshzad, Elnaz [3 ]
Moazzami, Bobak [2 ]
Mohammadpour, Zinat [2 ,4 ]
机构
[1] Univ Tehran Med Sci, Fac Pharm, Dept Clin Pharm, Tehran, Iran
[2] Univ Tehran Med Sci, Liver Transplantat Res Ctr, Imam Khomeini Hosp Complex, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran
[4] Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Adelaide, SA, Australia
来源
ANNALS OF GASTROENTEROLOGY | 2021年 / 34卷 / 03期
关键词
Nonalcoholic fatty liver disease; dietary interventions; cardio-metabolic risk factors; insulin resistance; lipid profile; MEDITERRANEAN DIET; AMERICAN ASSOCIATION; HEPATIC STEATOSIS; NATURAL-HISTORY; RESTRICTED DIET; STEATOHEPATITIS; EPIDEMIOLOGY; PATHOGENESIS; MANAGEMENT; DIAGNOSIS;
D O I
10.20524/aog.2021.0601
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Dietary modification is considered as one of the main strategies in the management of nonalcoholic fatty liver disease (NAFLD). The objective of this study was to systematically investigate the effect of dietary interventions on the cardio-metabolic risk factors, including lipid profile and insulin resistance in this population. Methods We searched electronic databases of PubMed and Scopus until January 2020 and included randomized controlled trials that compared the effect of dietary modifications vs. control on lipid profile and insulin resistance in patients with NAFLD. The random-effect analysis was performed to calculate pooled weighted mean differences (WMD). Results Our finding showed that serum triglycerides (TG) (n=5, WMD -38.50 mg/dL, 95% confidence interval [CI] -61.68 to -15.31; P=0.001) and total cholesterol (TC) (n=4, WMD -18.70 mg/dL, 95%CI -34.85 to -2.53; P=0.023) decrease following diet intervention along with marginally significant weight reduction (n=5, WMD -3.61 mg/dL, 95%CI -7.25 to 0.04; P=0.053). There was no change in the homeostatic model assessment for insulin resistance, high- and low-density lipoprotein (LDL) levels (P>0.05). Subgroup analysis revealed that Mediterranean diet reduced TG (n=2, WMD -57.52 mg/dL, 95%CI -75.73 to -39.31; P<0.001) and weight (n=2, WMD -7.59 Kg, 95%CI -13.53 to -1.66; P=0.012), and also increased LDL level (n=2, WMD 29.73 mg/dL, 95%CI 13.82-45.65; P<0.001). However, standard hypocaloric diet improved TC (n=2, WMD -23.20 mg/dL, 95%CI -36.96 to -9.44; P=0.001) and LDL (n=2, WMD -16.82 mg/dL, 95%CI -29.44 to -4.19; P=0.009). Conclusion Dietary modifications may improve serum TG, TC, and obesity in NAFLD.
引用
收藏
页码:415 / 423
页数:9
相关论文
共 50 条
  • [41] The effects of the Dietary Approaches to Stop Hypertension (DASH) diet on metabolic risk factors in patients with chronic disease: A systematic review and meta-analysis of randomized controlled trials
    Lari, Abolfazl
    Sohouli, Mohammad H.
    Fatahi, Somaye
    Cerqueira, Henrique S.
    Santos, Heitor O.
    Pourrajab, Behnaz
    Rezaei, Mahshid
    Saneie, Solaleh
    Rahideh, Seyedeh T.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (10) : 2766 - 2778
  • [42] Evaluation of HuoXueHuaYu therapy for nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trial
    Yunfei Cai
    Qiuer Liang
    Weihao Chen
    Minghao Chen
    Ruixue Chen
    Yun Zhang
    Ya Xiao
    Liguo Chen
    BMC Complementary and Alternative Medicine, 19
  • [43] Evaluation of HuoXueHuaYu therapy for nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trial
    Cai, Yunfei
    Liang, Qiuer
    Chen, Weihao
    Chen, Minghao
    Chen, Ruixue
    Zhang, Yun
    Xiao, Ya
    Chen, Liguo
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 19 (1):
  • [44] Blueberry and cardiovascular disease risk factors: A systematic review and meta-analysis of randomized controlled trials
    Miraghajani, Mayam
    Momenyan, Somayeh
    Arab, Arman
    Dehkordi, Ali Hasanpour
    Symonds, Micheal E.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 53
  • [45] Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials
    Kalogirou, Maria-Styliani
    Patoulias, Dimitrios
    Haidich, Anna-Bettina
    Akriviadis, Evangelos
    Sinakos, Emmanouil
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (03)
  • [46] Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials
    Ebrahimzadeh, Armin
    Ebrahimzadeh, Anahita
    Fooladshekan, Sara
    Mohseni, Shokouh
    Mohtashamian, Abbas
    Babajafari, Siavash
    Sohrabi, Zahra
    FOOD SCIENCE & NUTRITION, 2025, 13 (01):
  • [47] Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis
    Huang, Yi-Zhou
    Yang, Gang-Yi
    Wang, Cong
    Chen, Xing-Yu
    Zhang, Li-Li
    WORLD JOURNAL OF DIABETES, 2021, 12 (09) : 1576 - 1586
  • [48] Coffee Consumption and Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
    Wijarnpreecha, Karn
    Thongprayoon, Charat
    Ungprasert, Patompong
    HEPATOLOGY, 2016, 64 : 591A - 591A
  • [49] Helicobacter pylori and Risk of Nonalcoholic Fatty Liver Disease A Systematic Review and Meta-analysis
    Wijarnpreecha, Karn
    Thongprayoon, Charat
    Panjawatanan, Panadeekarn
    Manatsathit, Wuttiporn
    Jaruvongvanich, Veeravich
    Ungprasert, Patompong
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (05) : 386 - 391
  • [50] Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis
    Wijarnpreecha, Karn
    Thongprayoon, Charat
    Ungprasert, Patompong
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (02) : E8 - E12